|
Index of reports
> Cases resulting in life threatening events (9)
> Cases with Hepatitis Cholestatic (3)
Below is the selection of adverse event reports related to Flagyl (Metronidazole) that includes cases resulting in life threatening events where reactions include hepatitis cholestatic.
Adverse event in 53 year old male receiving Flagyl (Metronidazole)
Reported by a pharmacist from France on 2007-02-08
Patient: 53 year old male, weighing 50.0 kg (110.0 pounds)
Adverse reactions / side effects: Hepatitis Cholestatic
Adverse event resulted in: death, life threatening event
Suspect drug(s):
Moxifloxacin Hydrochloride
Dosage: total daily dose: 400 mg unit dose: 400 mg
Administration route: Oral
Indication: Aspergillosis
Start date: 2006-11-07
End date: 2006-12-01
Flagyl
Administration route: Oral
Indication: Aspergillosis
Start date: 2006-11-07
End date: 2006-12-01
Vfend
Dosage: unit dose: 200 mg
Administration route: Oral
Indication: Aspergillosis
Start date: 2006-11-13
End date: 2006-12-01
Other drugs received by patient: Xatral; Nicotinell; Motylio; Xanax
Adverse event in 53 year old male receiving Flagyl (Metronidazole)
Reported by a individual with unspecified qualification on 2007-01-31
Patient: 53 year old male
Adverse reactions / side effects: Metabolic Acidosis, Coagulopathy, Cholestasis, Pyrexia, Hepatitis Cholestatic, Renal Failure, Sepsis, Circulatory Collapse, Leukocytosis, Cardiovascular Disorder
Adverse event resulted in: death, life threatening event
Suspect drug(s):
Flagyl
Administration route: Oral
Indication: Aspergillosis
Start date: 2006-11-07
End date: 2006-12-01
Moxifloxacin Hydrochloride
Administration route: Oral
Indication: Aspergillosis
Start date: 2006-11-07
End date: 2006-12-01
Vfend
Administration route: Oral
Indication: Aspergillosis
Start date: 2006-11-13
End date: 2006-12-01
Adverse event in 53 year old male receiving Flagyl (Metronidazole)
Reported by a individual with unspecified qualification on 2007-01-16
Patient: 53 year old male
Adverse reactions / side effects: Metabolic Acidosis, Coagulopathy, Cholestasis, Pyrexia, Hepatitis Cholestatic, Renal Failure, Sepsis, Circulatory Collapse, Leukocytosis
Adverse event resulted in: death, life threatening event
Suspect drug(s):
Flagyl
Administration route: Oral
Start date: 2006-11-07
End date: 2006-12-01
Moxifloxacin Hydrochloride
Administration route: Oral
Start date: 2006-11-07
End date: 2006-12-01
Vfend
Administration route: Oral
Start date: 2006-11-13
End date: 2006-12-01
|
